Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance

Bibliographic Details
Published in:Frontiers in Pharmacology
Main Authors: Xixi Lin, Yongliang Jia, Xinwei Dong, Jian Shen, Yachao Jin, Yanyou Li, Fang Wang, Eitan Anenberg, Jiancang Zhou, Jianping Zhu, Xiaoping Chen, Qiangmin Xie, Yicheng Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Subjects:
lung cancer
Platinum complex
Water solubility
ROS/p53 pathway
cisplatin resistance
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.890886/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.890886/full

Similar Items